Leptin does not induce hypertrophy, cell cycle alterations, or production of MCP-1 in cultured rat and mouse cardiomyocytes

Endocrine Research

Volumn 31, Issue 4, 2005, Pages 375-386

  Piñeiro, Roberto ^a   Iglesias J , María ^a   Eiras, Sonia ^a   Viñuela, Juan ^a   Lago, Francisca ^a   González Juanatey, José R ^a,b  

^a Instituto de Salud Carlos III   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Cardiomyocytes; Cell cycle; Hypertrophy; Leptin; MCP 1

Indexed keywords

BROXURIDINE; LEPTIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HORMONE ACTION; MALE; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VITAL STAIN;

ANIMALS; APOPTOSIS; BISBENZIMIDE; CELL CYCLE; CELL GROWTH PROCESSES; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINE CCL2; FEMALE; LEPTIN; MALE; MICE; MICROSCOPY, FLUORESCENCE; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 32144464545     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.1080/07435800500456937     Document Type: Article

References (48)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372:425-432.
2. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395:763-770.
3. Hamilton BS, Paglia D, Kwan AY, Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med 1995; 1:953-956.
4. Considine RV, Sinha MK, Heiman ML, O'Rahilly S, Fewtrell M, Kattenhorn M, Lucas A, Deanfield J. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334:292-295.
5. Singhal A, Farooqi IS, Cole TJ, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, Mckee LJ, Bauer TL, Caro JF. Influence of leptin on arterial distensibility: A novel link between obesity and cardiovascular disease?. Circulation 2002; 106:1919-1924.
6. Lollmann B, Gruninger S, Stricker-Krongrad A, Chiesi M. Detection and quantification of the leptin receptor splice variants Ob-Ra, b, and, e in different mouse tissues. Biochem Biophys Res Commun 1997; 238:648-652.
7. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Wool EA, Monroe CA, Tepper RI. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83:1263-1271.
8. Emilsson V, Liu YL, Cawthorne MA, Morton NM, Davenport M. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 1997; 46:313-316.
9. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100:270-278.
10. Snitker S, Pratley RE, Nicolson M, Tataranni PA, Ravussin E. Relationship between muscle sympathetic nerve activity and plasma leptin concentration. Obes Res 1997; 5:338-340.
11. Lembo G, Vecchione C, Fratta L, Marino G, Trimarco V, d'Amati G, Trimarco B. Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 2000; 49:293-297.
12. Narkiewicz K, Kato M, Phillips BG, Pesek CA, Choe I, Winnicki M, Palatini P, Sivitz WI, Somers VK. Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects. J Hypertens 2001; 19:1089-1094.
13. Winnicki M, Phillips BG, Accurso V, van De Borne P, Shamsuzzaman A, Patil K, Navkiewicz K, Somers VK. Independent association between plasma leptin levels and heart rate in heart transplant recipients. Circulation 2001; 104:384-386.
14. Wolk R, Johnson BD, Somers VK. Leptin and the ventilatory response to exercise in heart failure. J Am Coll Cardiol 2003; 42:1644-1649.
15. Cooke JP, Oka RK.. Does leptin cause vascular disease?. Circulation 2002; 106:1904-1905.
16. Sader S, Nian M, Liu P. Leptin: A novel link between obesity, diabetes, cardiovascular risk, and ventricular hypertrophy. Circulation 2003; 108:644-646.
17. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vusan RS. Obesity and the risk of heart failure. N Engl J Med 2002; 347:305-313.
18. Toth MJ, Gottlieb SS, Fisher ML, Ryan AS, Nicklas BJ, Poehlman ET. Plasma leptin concentrations and energy expenditure in heart failure patients. Metabolism 1997; 46:450-453.
19. Leyva F, Anker SD, Egerer K, Stevenson JC, Kox WJ, Coats AJ. Hyperleptinaemia in chronic heart failure: Relationships with insulin. Eur Heart J 1998; 19:1547-1551.
20. Bottner A, Eisenhofer G, Friberg P, Rundqvist B, Bornstein SR. Hyperleptinaemia does not correlate with plasma catecholamine levels in chronic heart failure. Eur Heart J 1999; 20:1051-1052.
21. Doehner W, Pflaum CD, Rauchhaus M, Godsland IF, Egerer K, Cicoira M, Floreu VG, Sharma R, Bolger AP, Coats AJ, Anker SD, Strasburger CJ. Leptin, insulin sensitivity, and growth hormone binding protein in chronic heart failure with and without cardiac cachexia. Eur J Endocrinol 2001; 145:727-735.
22. Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 1999; 13:1231-1238.
23. Oda A, Taniguchi T, Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 2001; 47:141-150.
24. Parhami F, Tintut Y, Ballard A, Fogelman AM, Demer LL. Leptin enhances the calcification of vascular cells: Artery wall as a target of leptin. Circ Res 2001; 88:954-960.
25. Yen TT, Allan JA, Pearson DV, Schinitsky MR. Dissociation of obesity, hypercholesterolemia, and diabetes from atherosclerosis in ob/ ob mice. Experientia 1977; 33:995-996.
26. Nishina PM, Naggert JK, Verstuyft J, Paigen B. Atherosclerosis in genetically obese mice: The mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 1994; 43:554-558.
27. Katz AM. Maladaptive growth in the failing heart: The cardiomyopathy of overload. Cardiovasc Drugs Ther 2002; 16:245-249.
28. Nickola MW, Wold LE, Colligan PB, Wang GJ, Samson WK, Ren J. Leptin attenuates cardiac contraction in rat ventricular myocytes: Role of NO. Hypertension 2000; 36:501-505.
29. Rajapurohitam V, Gan XT, Kirshenbaum LA, Karmazyn M. The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ Res 2003; 93:277-279.
30. Xu FP, Chen MS, Wang YZ, Yi Q, Lin SB, Chen AF, Luo JD. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation 2004; 110:1269-1275.
31. Barouch LA, Berkowitz DE, Harrison RW, O'Donnell CP, Hare JM. Disruption of leptin signalling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 2003; 108:754-759.
32. Yang YY, Hu CJ, Chang SM, Tai TY, Leu SJ. Aspirin inhibits monocyte chemoattractant protein-1 and interleukin-8 expression in TNF-alpha stimulated human umbilical vein endothelial cells. Atherosclerosis 2004; 174:207-213.
33. Behr TM, Willette RN, Coatney RW, Berova M, Angermann CE, Anderson K, Sackner-Bernstein JD, Barone FC. Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality, and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease. J Hypertens 2004; 22:583-592.
34. Hayashidani S, Tsutsui H, Shiomi T, Ikeuchi M, Matsusaka H, Suematsa N, Wen J, Egashira K, Takeshita A. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2003; 108:2134-2140.
35. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M, Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001; 276:25096-25100.
36. Claycomb WC, Lanson NA Jr, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ Jr. HL-1: A cardiac muscle cell line that contracts and retains phenotypic characteristics of adult cardiomyocyte. Proc Natl Acad Sci USA 1998; 95:2979-2984.
37. Morton NM, Emilsson V, Liu YL, Cawthorne MA. Leptin action in intestinal cells. J Biol Chem 1998; 273:26194-26201.
38. Gonzalez-Juanatey JR, Iglesias MJ, Alcaide C, Pineiro R, Lago F. Doxazosin induces apoptosis in cardiomyocytes cultured in vitro by a mechanism that is independent of alpha1-adrenergic blockade. Circulation 2003; 107:127-131.
39. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: A new therapeutic target?. Circulation 2004; 109:1580-1589.
40. Haunstetter A, Izumo S. Toward antiapoptosis as a new treatment modality. Circ Res 2000; 86:371-376.
41. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1:1155-1161.
42. Lu C, Schwartzbauer G, Sperling MA, Devaskar SU, Thamotharan S, Robbins PD, McTiernan CF, Liu JL, Jiang J, Frank SJ, Menon RK. Demonstration of direct effects of growth hormone on neonatal cardiomyocytes. J Biol Chem 2001; 276:22892-22900.
43. Aguilera A, Bajo MA, Rebollo F, Diez JJ, Diaz C, Paiva A, Codoceo R, Selgas R. Leptin as a marker of nutrition and cardiovascular risk in peritoneal dialysis patients. Adv Perit Dial 2002; 18:212-217.
44. Pladevall M, Williams K, Guyer H, Sadurni J, Faices C, Ribes A, Pare C, Brotons C, Gabriel R, Serrano-Rios M, Haffner S. The association between leptin and left ventricular hypertrophy: A population-based cross-sectional study. J Hypertens 2003; 21:1467-1473.
45. Tajmir P, Ceddia RB, Li RK, Coe IR, Sweeney G. Leptin increases cardiomyocyte hyperplasia via extracellular signal-regulated kinase- and phosphatidylinositol 3-kinase-dependent signaling pathways. Endocrinolgy 2004; 145:1550-1555.
46. Umemoto Y, Tsuji K, Yang FC, Ebihara Y, Kaneko A, Furukawa S, Nakahata T. Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells. Blood 1997; 90:3438-3443.
47. Ghilardi N, Skoda RC. The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol Endocrinol 1997; 11:393-399.
48. Saad MF, Khan A, Sharma A, Michael R, Riad-Gabriel MG, Boyadjian R, Jinagouda SD, Steil GM, Kamdar V. Physiological insulinemia acutely modulates plasma leptin. Diabetes 1998; 47:544-549.